Clinical Trials Browser

Phase 2 × Terminated × reparixin × Clear all

NCT01861054 2021-05-14

Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer

Phase 2 Terminated

20 enrolled 16 charts

Breast Neoplasms